Literature DB >> 31969029

Moderate hyperthermic heating encountered during thermal ablation increases tumor cell activity.

Aurelia Markezana1, Muneeb Ahmed2, Gaurav Kumar2, Elina Zorde-Khvalevsky1, Nir Rozenblum1, Eithan Galun1, S Nahum Goldberg1,2,3.   

Abstract

Purpose: The aim of this study was to determine whether moderate hyperthermic doses, routinely encountered in the periablational zone during thermal ablation, activate tumor cells sufficiently to secrete pro-tumorigenic factors that can induce increased proliferation.Material and methods: R3230 rat mammary tumor cells and human cancer cell lines, MCF7 breast adenocarcinoma, HepG2 and Huh7 HCC, and HT-29 and SW480 colon adenocarcinoma, were heated in to 45 ± 1 °C or 43 ± 1 °C in vitro for 5-10 min and incubated thereafter at 37 °C for 1.5, 3 or 8 hr (n = 3 trials each; total N = 135). mRNA expression profiles of cytokines implicated in RF-induced tumorigenesis including IL-6, TNFα, STAT3, HGF, and VEGF, were evaluated by relative quantitative real-time PCR. HSP70 was used as control. c-Met and STAT3 levels were assessed by Western blot. Finally, naïve cancer cells were incubated with medium from R3230 and human cancer cells that were subjected to 43-45 °C for 5 or 10 min and incubated for 3 or 8 h at 37 °C in an xCELLigence or incuCyte detection system.
Results: Cell-line-specific dose and time-dependent elevations of at least a doubling in HSP70, IL-6, TNFα, STAT3, and HGF gene expression were observed in R3230 and human cancer cells subjected to moderate hyperthermia. R3230 and several human cell lines showed increased phosphorylation of STAT3 3 h post-heating and increased c-Met following heating. Medium of cancer cells subject to moderate hyperthermia induced statistically significant accelerated cell growth of all cell lines compared to non-heated media (p < 0.01, all comparisons).
Conclusion: Heat-damaged human tumor cells by themselves can induce proliferation of tumor by releasing pro-tumorigenic factors.

Entities:  

Keywords:  Radiofrequency ablation; interventional oncology; moderate hyperthermia; tumor growth; tumorigenesis

Mesh:

Year:  2020        PMID: 31969029      PMCID: PMC7654730          DOI: 10.1080/02656736.2020.1714084

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  38 in total

Review 1.  Principles of and advances in percutaneous ablation.

Authors:  Muneeb Ahmed; Christopher L Brace; Fred T Lee; S Nahum Goldberg
Journal:  Radiology       Date:  2011-02       Impact factor: 11.105

2.  Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.

Authors:  Xiaodong Wang; Constantinos T Sofocleous; Joseph P Erinjeri; Elena N Petre; Mithat Gonen; Kinh G Do; Karen T Brown; Anne M Covey; Lynn A Brody; William Alago; Raymond H Thornton; Nancy E Kemeny; Stephen B Solomon
Journal:  Cardiovasc Intervent Radiol       Date:  2012-04-26       Impact factor: 2.740

3.  Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation.

Authors:  Gaurav Kumar; S Nahum Goldberg; Svetlana Gourevitch; Tatyana Levchenko; Vladimir Torchilin; Eithan Galun; Muneeb Ahmed
Journal:  Radiology       Date:  2017-09-06       Impact factor: 11.105

Review 4.  Interleukin-6 signaling pathway in targeted therapy for cancer.

Authors:  Yuqi Guo; Feng Xu; TianJian Lu; Zhenfeng Duan; Zhan Zhang
Journal:  Cancer Treat Rev       Date:  2012-05-29       Impact factor: 12.111

5.  Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.

Authors:  Luigi Solbiati; Muneeb Ahmed; Luca Cova; Tiziana Ierace; Michela Brioschi; S Nahum Goldberg
Journal:  Radiology       Date:  2012-10-22       Impact factor: 11.105

6.  Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10.

Authors:  Joseph P Erinjeri; Contessa T Thomas; Alaiksandra Samoilia; Martin Fleisher; Mithat Gonen; Constantinos T Sofocleous; Raymond H Thornton; Robert H Siegelbaum; Anne M Covey; Lynn A Brody; William Alago; Majid Maybody; Karen T Brown; George I Getrajdman; Stephen B Solomon
Journal:  J Vasc Interv Radiol       Date:  2013-04-10       Impact factor: 3.464

7.  Accelerated perinecrotic outgrowth of colorectal liver metastases following radiofrequency ablation is a hypoxia-driven phenomenon.

Authors:  Maarten W Nijkamp; Jarmila D W van der Bilt; Menno T de Bruijn; I Quintus Molenaar; Emile E Voest; Paul J van Diest; Onno Kranenburg; Inne H M Borel Rinkes
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

8.  Hepatic Radiofrequency Ablation-induced Stimulation of Distant Tumor Growth Is Suppressed by c-Met Inhibition.

Authors:  Muneeb Ahmed; Gaurav Kumar; Marwan Moussa; Yuanguo Wang; Nir Rozenblum; Eithan Galun; S Nahum Goldberg
Journal:  Radiology       Date:  2015-09-29       Impact factor: 11.105

9.  Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis.

Authors:  In Hye Jung; Jeffrey Hyun-Kyu Choi; Yong-Yoon Chung; Ga-Lam Lim; Young-Nyun Park; Seung Woo Park
Journal:  Neoplasia       Date:  2015-07       Impact factor: 5.715

10.  Application of xCELLigence RTCA Biosensor Technology for Revealing the Profile and Window of Drug Responsiveness in Real Time.

Authors:  Dan Kho; Christa MacDonald; Rebecca Johnson; Charles P Unsworth; Simon J O'Carroll; Elyce du Mez; Catherine E Angel; E Scott Graham
Journal:  Biosensors (Basel)       Date:  2015-04-16
View more
  5 in total

1.  Image-Guided Radiofrequency Hyperthermia (RFH)-Enhanced Direct Chemotherapy of Hepatic Tumors: The Underlying Biomolecular Mechanisms.

Authors:  Kun Qian; Minjiang Chen; Feng Zhang; Jeffrey Forris Beecham Chick; Hongxiu Ji; Chuansheng Zheng; Xiaoming Yang
Journal:  Front Oncol       Date:  2021-01-28       Impact factor: 6.244

2.  Biopsy and Margins Optimize Outcomes after Thermal Ablation of Colorectal Liver Metastases.

Authors:  Nikiforos Vasiniotis Kamarinos; Efsevia Vakiani; Mithat Gonen; Nancy E Kemeny; Carlie Sigel; Leonard B Saltz; Karen T Brown; Anne M Covey; Joseph P Erinjeri; Lynn A Brody; Etay Ziv; Hooman Yarmohammadi; Henry Kunin; Afsar Barlas; Elena N Petre; Peter T Kingham; Michael I D'Angelica; Katia Manova-Todorova; Stephen B Solomon; Constantinos T Sofocleous
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

3.  Sublethal hyperthermia enhances anticancer activity of doxorubicin in chronically hypoxic HepG2 cells through ROS-dependent mechanism.

Authors:  Qi Wang; Hui Zhang; Qian-Qian Ren; Tian-He Ye; Yi-Ming Liu; Chuan-Sheng Zheng; Guo-Feng Zhou; Xiang-Wen Xia
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

4.  How large is the periablational zone after radiofrequency and microwave ablation? Computer-based comparative study of two currently used clinical devices.

Authors:  Macarena Trujillo; Punit Prakash; Pegah Faridi; Aleksandar Radosevic; Sergio Curto; Fernando Burdio; Enrique Berjano
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

Review 5.  The two facets of gp130 signalling in liver tumorigenesis.

Authors:  Dirk Schmidt-Arras; Eithan Galun; Stefan Rose-John
Journal:  Semin Immunopathol       Date:  2021-05-28       Impact factor: 9.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.